AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,000 | -64.7% | 7,428 | 0.0% | 0.00% | – |
Q4 2021 | $17,000 | -19.0% | 7,428 | 0.0% | 0.00% | – |
Q3 2021 | $21,000 | -25.0% | 7,428 | 0.0% | 0.00% | – |
Q2 2021 | $28,000 | +12.0% | 7,428 | 0.0% | 0.00% | – |
Q1 2021 | $25,000 | +19.0% | 7,428 | 0.0% | 0.00% | – |
Q4 2020 | $21,000 | +10.5% | 7,428 | 0.0% | 0.00% | – |
Q3 2020 | $19,000 | -81.0% | 7,428 | 0.0% | 0.00% | – |
Q2 2020 | $100,000 | +194.1% | 7,428 | +66.3% | 0.00% | – |
Q1 2020 | $34,000 | +21.4% | 4,466 | 0.0% | 0.00% | – |
Q4 2019 | $28,000 | -31.7% | 4,466 | -46.9% | 0.00% | – |
Q2 2019 | $41,000 | -40.6% | 8,418 | 0.0% | 0.00% | – |
Q1 2019 | $69,000 | +53.3% | 8,418 | 0.0% | 0.00% | – |
Q4 2018 | $45,000 | +9.8% | 8,418 | +80.1% | 0.00% | – |
Q3 2018 | $41,000 | -12.8% | 4,675 | 0.0% | 0.00% | – |
Q2 2018 | $47,000 | +4.4% | 4,675 | 0.0% | 0.00% | – |
Q1 2018 | $45,000 | -34.8% | 4,675 | 0.0% | 0.00% | – |
Q4 2017 | $69,000 | – | 4,675 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |